Dalent Medical

Executive Summary

Dalent Medical, founded in 2018 and headquartered in Miami, is a medical device company dedicated to advancing ENT surgical and interventional care. The company's core focus is on developing cost-effective, innovative tools that improve patient outcomes for sinus-related conditions and Eustachian tube dysfunction. Its flagship product, the Sinusleeve® Balloon, is a value-priced device for balloon sinus dilation, aiming to provide a more affordable alternative without compromising quality. By addressing common ENT disorders with a streamlined approach, Dalent Medical seeks to empower physicians and enhance accessibility to effective treatments. Dalent Medical operates in a growing market driven by the increasing prevalence of chronic sinusitis and the shift toward minimally invasive procedures. The Sinusleeve® Balloon, already commercially available, positions the company to capture share in the balloon sinus dilation segment. However, as a relatively young company with limited public financial data, its success hinges on expanding commercial adoption, securing regulatory clearances for broader indications, and demonstrating clinical effectiveness. With a lean operational model and a clear value proposition, Dalent Medical has the potential to disrupt the established players in the ENT device space, though it faces challenges in scaling and competitive differentiation.

Upcoming Catalysts (preview)

• H2 2026FDA 510(k) Clearance for New Sinus Indications80% success
• Q4 2026Strategic Hospital Partnership or GPO Contract70% success
• H1 2027Publication of Clinical Data Showing Superior Outcomes60% success